| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Matrix Capital Management Company, LP is a 10% Owner at Aura Biosciences, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 1 sell.
Estimated insider holdings value: $84.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | 10% Owner | Sell | 7,500,000 | $1.33 | $9,975,000.00 | -53.7% | +93.6% | - | |
| Nov 9, 2023 | AURA Aura Biosciences, Inc. | 10% Owner | Buy | 1,560,000 | $9.00 | $14,040,000.00 | +29.1% | +14.0% | +55.0% | |
| Jun 20, 2023 | ZNTL Zentalis Pharmaceuticals, Inc. | 10% Owner | Buy | 4,760,000 | $22.66 | $107,861,600.00 | +51.7% | -21.1% | -81.6% | |
| Dec 5, 2022 | AURA Aura Biosciences, Inc. | 10% Owner | Buy | 1,250,000 | $12.00 | $15,000,000.00 | +30.4% | -12.8% | -32.0% | |
| Nov 2, 2021 | AURA Aura Biosciences, Inc. | 10% Owner | Buy | 1,785,000 | $14.00 | $24,990,000.00 | +76.7% | +6.0% | -28.4% |